Immutep
IMMP
$2.01
Share price
0.50%
Change (1 day)
-49.62%
Change (1 year)
Categories
Revenue for Immutep (IMMP)
Revenue in 2020: $5.75 M
According to Immutep's latest financial reports the company's current revenue (TTM) is -$0.01 M. In 2020 the company made a revenue of $5.75 M an increase over the years 2019 revenue that were of $0.09 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immutep from 2010 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 | $5.75 M | 5782.01% |
| 2019 | $0.09 M | -94.72% |
| 2018 | $1.85 M | |
| 2016 | $0.12 M | |
| 2012 | $1.57 M | |
| 2010 | $0.53 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $4.65 B | -1,674,820,243.88% | 🇺🇸 USA |
 FibroGen FGEN | $0.25 B | -92,700,459.71% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $8.65 M | -3,113,817.99% | 🇺🇸 USA |